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RISK FACTORS FOR TARDIVE DYSKINESIA 
SUNIL DATTA, T.P.SUBHALAKSHMI, LJEYASEELAN, K.KURUVILLA 
Three hundred and fifty three patients who had been on antipsychotics for three months or more were 
assessed using Simpson Tardive Dyskinesia Rating Scale. 40.2% of these patients, who merited a 
diagnosis of probable Tardive Dyskinesia (TD) by the Schooler and Kane criteria, were reassessed 
three months later and 25.5% of the total sample were found to have persistent TD. Age, total 
antipsychotic dosage and duration of antipsychotic exposure were found to be positively correlated 
with persistent TD. 
INTRODUCTION 
A variety of risk factors have been implicated in 
the aetiology in Tardive Dyskinesia (TD) (Kane & 
Smith, 1982). However there are few studies that 
have utilized a well defined criteria for diagnosis of 
TD like the Schooler and Kane criteria (1982) and 
looked into the putative risk factors in non-western 
population. Wc report our findings of such a study 
on an Indian population. 
METHODS 
For a period of three months all outpatients at-
tending the psychiatry outpatient clinic who had 
been on antipsychotics for three months or more 
were surveyed for the presence of TD. All patients 
were surveyed by a single rater who was blind to the 
diagnosis and pharmacotherapeutic status of the 
patient. They were rated on the Simpson Tardive 
Dyskinesia Rating Scale (Simpson et al, 1979) 
which had been standardized in our setting and 
inter-rater reliability was established. Intraclass cor-
relation coefficient (r) for face, neck and trunk, 
upper and lower extremities were 0.84, 0.93, 0.71 
and 0.44 respectively. All ratings were carried out 
between 2.00 and 4.00 p.m. Patients who met the 
diagnosis of "Probable TD" according to
 ;ie 
Schooler and Kane criteria became the study group 
and the patients who did not meet the criteria forrncd 
the comparison group. All patients who met the 
diagnosis of probable TD were resurveyed three 
months after the initial assessment. 
The information on risk factors was collected and 
analyzed by persons who were blind to the patients' 
TD status. The factors examined were age, sex, total 
antipsychotic, anticholinergic, antidepressant and 
lithium exposure, prior extrapyramidal syndromes, 
duration of treatment and diagnosis. Relative risk 
and 95% confidence intervals were computed. The 
Chi-square test was used to assess the significance 
of relative risk. Logistic regression analysis was 
done using EGRET software. 
RESULTS 
The total number of patients surveyed were 365. 
However 12 patients who received a diagnosis of 
Probable TD did not come for a follow-up assess-
ment after three months and were dropped from the 
study; hence, only 353 patients completed the study. 
The number of patients having TD and the distribu-
tion of the types of TD are given in Table 1, and the 
results of the bivariate analyses are presented in 
Table 2. 
Tabla 1 
Distribution of typa of Tardiva Dyskinasia 
Non -Persistent TD 
Masked - Probable 
Transisent 
Withdrawal 
Persistent TD 
Normal 
No. 
7 
27 
18 
90 
211 
% 
2.0 
7.6 
5.1 
25.5 
59.8 
Age, total antipsychotic exposure and duration of 
antipsychotic exposure were significantly as-
sociated with TD. When TD was divided into per-
sistent and non-persistent TD and analyzed 
separately, the above risk factors were seen to be 
associated with persistent TD only. 
The results of logistic regression analysis are 
presented in Table 3. After controlling for other 
variables, age and duration of antipsychotic ex-
posure were significantly associated with TD. When 
TD was divided into Persistent and Non-Persistent 
TD and analyzed separately the above risk factors 
were seen to be associated with Persistent TD only. 
DISCUSSION 
The mean age of our sample was 33.5 years and 
in our patient population, increasing age was sig-
nificantly associated with TD. This agrees with find-
ings on Caucasian population literature which 
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Crude Relative Risk and 95 % Confidence Interval 
Non-PersistentTD 
vs 
Normal 
RR CI 
Persistent TD TD 
vs vs 
Normal Normal 
RR CI RR CI 
1 Age (years) 
<20 
21-30 
31-40 
41-50 
>51 
2. Sex 
Male 
Female 
1.0 
1.0 
1.2 
2.0; 
2.7 
1.0 
1.1 
0.3-2.7 
0.6-2.4 
1.0-4.0 
1.3-5.7 
0.7-1.7 
1.3 
1.0 
1.4 
1.8* 
2.0* 
1.0 
0.6' 
0.7-1.9 
0.8-2.2 
1.1-3.0 
1.1-3.7 
1.1 0.7-1.9 
1.0 
1.3 0.9-1.8 
1.7" 1.1-2.4 
1.9" 1.3-2.8 
0.4-0.9 
3. Antipsychotic Exposure 
<1,00,000 1.0 1.0 
1,00,001-
10,00,000 1.3 0.7-2.2 2.1 
>10,00,001 1.3 0.6-3.1 2.5" 
4. Anticholinergic Exposure 
<1,000 1.0 1.0 
1,001-10,000 0.9 0.5-1.6 1.4 
> 10,001 1.9* 1.0-3.7 2.1* 
5. Antidepressant Exposure 
<10,000 1.0 
10,001 -
1,00,000 1.2 0.7-2.2 
>1,00,001 0.7 0.2-2.8 
6. Total Lithium Exposure 
1.0 
0.8 
1.0 
0.6-1.1 
<1,00,000 1.0 
1,00,001 -
10,00,000 1.0 
>10,00,001 1.0 
7. Prior EPS 
No 1.0 
Yes 
8. Duration (months) 
1.0 
0.9 
0.8 
1.0 
0.6-2.1 0.7 
0.3-3.6 1.6 
1.0 
1.3-3.4 1.6 
1.4-4.5 1.7" 
1.0 
0.9-2.1 1.2 
1.3-3.4 1.7" 
1.0 
0.5-1.4 1.0 
0.3-1.9 0.8 
1.0 
0.3-1.3 0.8 
0.9-2.8 1.3 
1.1-2.2 
1.1-2.6 
0.9-1.5 
1.2-2.4 
0.7-1.4 
0.4-1.6 
0.5-1.3 
0.8-2.1 
1.0 
1.2 0.5-2.9 1.9 0.9-4.0 1.6 0.9-2.9 
6 
7-12 
13-24 
24-60 
61 
1.0 
0.5 
1.2 
1.8 
1.4 
0.2-1.5 
0.6-2.5 
0.9-3.7 
0.7-3.0 
». Diagnosis 
Schizophrenia 1.0 
Affective 
Disorder 0.8 
Paranoid state 1.2 
1.0 
1.8 
2.5' 
4.7" 
4.2" 
1.0 
0.7-4.2 
1.1-5.8 
2.2-9.9 
2.0-9.1 
0.1-1.3 0.7 
0.5-2.6 1.1 
0.5-1.0 
0.6-1.8 
1.1 
1.6 
2.4" 
2.1" 
1.0 
0.8 
1.0 
0.6-1.8 
0.9-2.6 
'1.5-3.7 
'1.3-3.4 
0.6-1.0 
0.7-1.6 
RR=Relative Risk; Cl=95% Confidence Interval 
P<.05;"p<.01;***p<.001 
Table 3 
Results of Logistic Regression Analysis. 
Variables Persistent TD 
1. Age (years) 
<20 
21-30 
31-40 
41-50 
>51 
2. Sex 
Male 
Female 
OR 
2.6 
1.0 
1.5 
2.4 
3.5 
1.0 
0.5 
3Antipsychdtic Exposure 
<1,00,000 
1,00,001-10,00,000 
>10,00,001 
1.0 
1.0 
0.6 
4Anticholinergic Exposure 
<1,000 
1,001-10,000 
>10,001 
1.0 
0.6 
1.0 
5. Antidepressant Exposure 
<1,000 
10,001-1,00,000 
>1,00,001 
1.0 
0.8 
0.6 
6. Total Lithium Expoaure 
<1,00,000 
1,00,001-10,00,000 
> 10,00,001 
7. Prior EPS 
No 
Yes 
S.Duration (months) 
0-6 
7-12 
13-24 
24-60 
61 of over 
S.Diagnoais 
Schizophrenia 
Affective Disorder 
Paranoid State 
1.0 
0.5 
2.0 
1.0 
2.4 
1.0 
2.6 
4.1 
14.5"* 
10.2" 
1.0 
1.2 
2.0 
vs Normal 
CI 
1.0-7.0 
0.7 
1.0 
1.1 
0.3 
0.4 
0.1 
0.3 
0.2 
0.3 
0.1 
0.2 
0.5 
0.9 
0.8 
1.2 
3.8 
2.2 
0.5 
0.7 
3.2 
5.8 
10.9 
1.0 
2.6 
2.7 
1.4 
3.6 
2.0 
2.6 
1.4 
7.9 
6.0 
7.9 
14.0 
56.5 
45.8 
2.7 
5.7 
TD' 
OR 
1.7 
1.5 
2.6 
3.7 
1.0 
0.8 
1.0 
0.6 
0.6 
1.3 
1.1 
0.6 
0.7 
1.6 
1.9 
1.3 
2.4 
6.8" 
4.0* 
1.0 
2.2 
vs Normal 
CI 
0.7-4.0 
0.8 2.8 
1.3 5.4 
1.4 9.8 
0.5 1.3 
0.5 2.2 
0.2 2.1 
0.3 1.2 
0.4 4.3 
0.5 2.2 
0.2 2.0 
0.3 1.6 
0.5 5.1 
0.9 3.9 
0.6 3.4 
0.9 6.2 
'2.3 19.8 
1.2 13.8 
0.4 1.9 
0.9 5.2 
OR = Odds ratio; CI = 95% Confidence Interval 
"p<.05; "p<.01; *"p<.001 
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suggest tbat age is almost linearly related to 
prevalence ofTD from 20 to 40 years (Chouinard et 
al.1986). 
The mean duration of exposure to antipsychotic 
medications was 33.4 months in our patient popula-
tion. The prevalence of TD was strongly correlated 
with the duration of exposure to antipsychotic and 
this also agrees with studies done on Caucasian 
population (Kane et al, 1986). 
An interesting finding emerged with regard to 
total antipsychotic exposure. Most studies which 
show a positive association between total antip-
sychotic exposure and TD, involved samples with 
relatively low cumulative drug exposure. As Kane 
and Smith (1982) point out, perhaps for those who 
are vulnerable to the development of TD, a dose 
response relationship occurs at relatively low 
cumulative doses, whereas for those without this 
underlying vulnerability increasing doses beyond 
this range may not lead to substantial increase in the 
risk of TD. In our study, the mean cumulative dose 
was 362,985 mgms chlorpromazine equivalent, 
which is on the lower side of the usual cumulative 
antipsychotic dose reported in studies on TD (Kane 
& Smith, 1982) and this was found to be significant-
ly correlated with persistent TD in the bivariate 
analysis. However, on multivariate analysis, this 
correlation did not reach significant level. This may 
mean that in our population, the 'threshold' of ex-
posure to antipsychotic exposure for development of 
TD is below this cumulative dose. Perhaps further 
studies on lower cumulative dose may establish a 
positive correlation. 
In our patient population, the sex of the patient 
was not found to be significantly associated with 
development of TD. Most recent reviews indicate 
that the magnitude of sex difference in TD (i.c, 
females having a higher prevalence of TD) increased 
with increasing age (Chouinard et al, 1986). Our 
sample was relatively young (mean age 33.53) and 
this could be the reason for the insignificant dif-
ference between the sexes. Diagnosis, exposure to 
lithium carbonate and tricyclic antidepressants were 
not correlated with the prevalence of TD. Though 
there was a correlation with the use of anticholiner-
gics on bivariate analysis, this disappeared on mul-
tivariate analysis. Since longer duration of treatment 
with antipsychotics invariably results in higher 
cumulative dose of anticholinergics, this finding 
suggests that it may not be the use of anticholinergics 
per se which is important in the genesis of TD, but 
only the duration of exposure to antipsychotics. 
One of the major limitations of the study was that 
there was a single rater for all the TD assessments; 
but the good inter-rater reliability which was estab-
lished at the beginning of the study and the fact that 
the TD rater was blind to the patients phar-
macotberapeutic status and those who collected in-
formation on possible risk factors were blind to the 
patient's TD status decreased the chances of ob-
server bias. Another limitation was that although the 
information regarding the past medication was 
gathered from the patient's hospital charts in most 
cases, in a few, the information had to be based on 
the reports from patients and their relatives. This 
could have been erroneous, even though a great 
effort was made to be as accurate as possible. 
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